🇺🇸 FDA
Pipeline program

Placebo tablets are produced with the same appearance as the Valganciclovir tablets, with the same content except for the active compound., VALGANCICLOVIR

Protocol number 8

Phase 2 small_molecule active

Quick answer

Placebo tablets are produced with the same appearance as the Valganciclovir tablets, with the same content except for the active compound., VALGANCICLOVIR for Glioblstoma WHO grade IV is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Glioblstoma WHO grade IV
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials